Search Results - "OHSHIMA, Etsuo"

Refine Results
  1. 1

    Intranasal administration of polysulfide prevents neurodegeneration in spinal cord and rescues mice from delayed paraplegia after spinal cord ischemia by Kanemaru, Eiki, Miyazaki, Yusuke, Marutani, Eizo, Ezaka, Mariko, Goto, Shunsaku, Ohshima, Etsuo, Bloch, Donald B., Ichinose, Fumito

    Published in Redox biology (01-04-2023)
    “…Delayed paraplegia is a devastating complication of thoracoabdominal aortic surgery. Hydrogen sulfide (H2S) was reported to be protective in a mouse model of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Differential Effects of PDE4 Inhibitors on Cortical Neurons and T-Lymphocytes by Hirose, Ryo, Manabe, Haruhiko, Yanagawa, Koji, Ohshima, Etsuo, Ichimura, Michio

    “…Inhibitors of PDE4 (cAMP-specific phosphodiesterase) induce side effects, including nausea and emesis, that limit their therapeutic potential. We investigated…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Solubilization and stabilization of lipoic acid trisulfide by creation of various β-cyclodextrin clathrates by Tomonaga, Shoichiro, Ishimaru, Hiroaki, Isobe, Takahiro, Ohshima, Etsuo, Kitagaki, Shinji

    “…Lipoic acid trisulfide, a sulfane sulfur-containing trisulfide of α-lipoic acid, holds promise in pharmaceuticals, yet knowledge gaps persist regarding its…”
    Get full text
    Journal Article
  6. 6

    One-Pot Synthesis of Glutathione Trisulfide from Oxidized Glutathione by Tomonaga, Shoichiro, Shimokawa, Ikumi, Nuno, Takahiro, Ishimaru, Hiroaki, Isobe, Takahiro, Ohshima, Etsuo, Kitagaki, Shinji

    Published in Journal of organic chemistry (02-08-2024)
    “…The excellent medicinal efficacy of glutathione trisulfide, an endogenous compound consisting of sulfane sulfur and two molecules of reduced glutathione, has…”
    Get full text
    Journal Article
  7. 7

    Unique binding pocket for KW-4679 in the histamine H1 receptor by NONAKA, H, OTAKI, S, OHSHIMA, E, KONO, M, KASE, H, OHTA, K, FUKUI, H, ICHIMURA, M

    Published in European journal of pharmacology (12-03-1998)
    “…The histamine H1 receptor has an aspartate (Asp) residue in transmembrane helix 3 (TM3), which is well-conserved among biogenic amine receptors. The Asp…”
    Get full text
    Journal Article
  8. 8

    Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata by Furukawa, Nobuya, Arai, Nobutaka, Goshima, Yoshio, Miyamae, Takeaki, Ohshima, Etsuo, Suzuki, Fumio, Fujita, Kiyohide, Misu, Yoshimi

    Published in Journal of neurochemistry (01-02-2001)
    “…Glutamate is implicated in neuronal cell death. Exogenously applied DOPA by itself releases neuronal glutamate and causes neuronal cell death in in vitro…”
    Get full text
    Journal Article
  9. 9

    DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats by Arai, Nobutaka, Furukawa, Nobuya, Miyamae, Takeaki, Goshima, Yoshio, Sasaki, Yukio, Ohshima, Etsuo, Suzuki, Fumio, Fujita, Kiyohide, Misu, Yoshimi

    Published in Neuroscience letters (23-02-2001)
    “…In rat striata, DOPA released is a causal factor for glutamate release and resultant delayed neuron death by four-vessel occlusion. Nanomolar DOPA cyclohexyl…”
    Get full text
    Journal Article
  10. 10

    Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives by Ohshima, Etsuo, Otaki, Shizuo, Sato, Hideyuki, Kumazawa, Toshiaki, Obase, Hiroyuki, Ishii, Akio, Ishii, Hidee, Ohmori, Kenji, Hirayama, Noriaki

    Published in Journal of medicinal chemistry (01-05-1992)
    “…A new series of 11-substituted 6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid derivatives was synthesized and demonstrated to be orally active antiallergic…”
    Get full text
    Journal Article
  11. 11

    Recent development of new drugs for the treatment of allergic diseases by Ohmori, Kenji, Adachi, Kei, Manabe, Haruhiko, Harada, Daisuke, Ohshima, Etsuo

    Published in Nihon yakurigaku zasshi (2004)
    “…Due to the prevalence of allergic diseases such as bronchial asthma, allergic rhinoconjunctivitis and dermallergosis, efforts at the discovery of novel and…”
    Get more information
    Journal Article
  12. 12

    Pharmacological, Pharmacokinetic and Clinical Properties of Olopatadine Hydrochloride, a New Antiallergic Drug by Ohmori, Kenji, Hayashi, Ken-ichi, Kaise, Toshihiko, Ohshima, Etsuo, Kobayashi, Satoshi, Yamazaki, Takashi, Mukouyama, Akimichi

    Published in Japanese Journal of Pharmacology (2002)
    “…Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel…”
    Get full text
    Journal Article
  13. 13

    Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist by Sato, Takashi, Iwase, Miho, Miyama, Motoki, Komai, Masato, Ohshima, Etsuo, Asai, Akira, Yano, Hiroshi, Miki, Ichiro

    Published in Pharmacology (01-07-2013)
    “…CC chemokine receptor 4 (CCR4) is a G protein-coupled receptor that regulates the chemotaxis of Th2 lymphocytes, which are key players in allergic diseases…”
    Get more information
    Journal Article
  14. 14

    Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation by Sato, Takashi, Komai, Masato, Iwase, Miho, Kobayashi, Katsuya, Tahara, Harunobu, Ohshima, Etsuo, Arai, Hitoshi, Miki, Ichiro

    Published in Pharmacology (01-01-2009)
    “…CC chemokine receptor 4 (CCR4) is expressed on Th2 cells, found in inflamed tissues of allergic diseases, and is therefore suspected to be involved in the…”
    Get more information
    Journal Article
  15. 15

    Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain by Hirose, Ryo, Manabe, Haruhiko, Nonaka, Hiromi, Yanagawa, Koji, Akuta, Kaori, Sato, Soichiro, Ohshima, Etsuo, Ichimura, Michio

    Published in European journal of pharmacology (14-11-2007)
    “…We employed an ex vivo [ 3H]rolipram binding experiment to elucidate the mechanism of emetic activity of phosphodiesterase 4 inhibitors. In Suncus murinus (an…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    l-DOPA Cyclohexyl Ester Is a Novel Potent and Relatively Stable Competitive Antagonist Against l-DOPA Among Several l-DOPA Ester Compounds by Furukawa, Nobuya, Goshima, Yoshio, Miyamae, Takeaki, Sugiyama, Yoshinobu, Shimizu, Minako, Ohshima, Etsuo, Suzuki, Fumio, Arai, Nobutaka, Fujita, Kiyohide, Misu, Yoshimi

    Published in Japanese Journal of Pharmacology (2000)
    “…We explored l-DOPA esters with chemically bulky structures to find a potent stable competitive antagonist against l-DOPA, compared to DOPA methyl ester (DOPA…”
    Get full text
    Journal Article
  19. 19
  20. 20